White label ELPA - ClinicalTrials.eu

Study on Rocatinlimab for Adolescents Aged 12-17 with Moderate-to-Severe Atopic Dermatitis

Not yet recruiting

3 1 1 1
Investigated diseases:
- Dermatitis atopic
Investigated drugs:
- Rocatinlimab
+3
Study on the Effectiveness of High-Dose Vitamin C for Patients with Shock After Cardiac Arrest

Not yet recruiting

2 1 1 1
Investigated drugs:
Study of Tiragolumab, Atezolizumab, and Chemotherapy for Patients with Non-Small Cell Lung Cancer (NSCLC)

Not yet recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Atezolizumab
- Tiragolumab
Study on the Safety and Effects of Resatorvid and Filgrastim for Patients with Severe Alcoholic Hepatitis and Acute-on-Chronic Liver Failure

Not yet recruiting

2 1 1
Investigated diseases:
- Acute on chronic liver failure
- Hepatitis alcoholic
Investigated drugs:
Study on the Effects of RO7200220 for Patients with Uveitic Macular Edema

Not yet recruiting

3 1 1
Investigated diseases:
- Macular oedema
Investigated drugs:
- Humanised Igg2 Monoclonal Antibody Against Interleukin-6
+1
Study on Switching to Doravirine and Islatravir for People with HIV-1 on Antiretroviral Therapy

Not yet recruiting

3 1 1 1
Investigated diseases:
- HIV infection
Investigated drugs:
Study on Doravirine and Islatravir for People with HIV-1 Previously Treated with the Same Drug Combination

Not yet recruiting

3 1 1
Investigated diseases:
- HIV infection
Investigated drugs:
- Doravirine
- Islatravir
Study on Switching HIV Treatment to Doravirine and Islatravir for Patients with HIV-1

Not yet recruiting

3 1 1
Investigated diseases:
- HIV infection
Investigated drugs:
Study on Early Detection of Triple-Negative Breast Cancer Relapse Using [68Ga]Ga-FAPI-46 for Patients at High Risk

Not yet recruiting

2 1 1
Investigated diseases:
- Triple negative breast cancer
Investigated drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Study on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet’s Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease

Not yet recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Filgotinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies